SREBF1 and fatty liver disease: showed that 2’FL protected the liver against hepatic steatosis in obese mice by reducing microvesicular steatosis, partly mediated by activating the gene ACOX1 (involved in lipid catabolism) and deactivating SREBF1 (involved in lipogenesis).[28] Similar results were found by Lee et al.